Sarcoidosis Lung Transplantation Waitlist Mortality, a National Registry Database Study
نویسندگان
چکیده
The Lung Allocation Score prioritizes lung transplantation candidates balancing waitlist-mortality and post-transplant survival. score groups sarcoidosis based on mean pulmonary artery pressure: ≤30 mmHg (Sarcoidosis A) are grouped with COPD >30 D) idiopathic fibrosis. We hypothesize that have a higher than other within their LAS grouping. This is retrospective cohort study of consecutive from the Scientific Registry Transplant Recipients database May 2005 to 2019. included ≥18 y/o diagnosed sarcoidosis, or IPF. Univariate, multivariate survival estimate analysis were performed. identified 385 A, 642 D, 7081 COPD, 10 639 IPF candidates. 17.3% 14.8% IPF, 14.3% 9.8% died awaiting transplant. Sarcoidosis A was an independent risk factor for waitlist-mortality. had lower waitlist probability compared COPD. D highest in first 60 days after listing. Based our results grouping allocation systems should be revised mitigate disparity.
منابع مشابه
Lung transplantation in sarcoidosis.
Lung transplantation (LT) is an appropriate therapeutic option for patients with severe, fibrocystic pulmonary sarcoidosis refractory to medical therapy. Survival rates following LT for sarcoidosis are generally comparable to other indications. Timing of transplantation for patients with sarcoidosis is challenging because mortality rates are high (27 to 53%) among sarcoid patients awaiting LT. ...
متن کاملThe migrated liver transplantation candidate: waitlist time affects mortality.
prolong biologic treatment in pediatric patients, we cannot make a generalized statement recommending early surgical treatment for these patients. An individualized decision made by the pediatric gastroenterologist, surgeon, patient, and parents of the patient is critical. At the same time, their study can be used as a reference to bring up an intellectual discussion for parents to understand t...
متن کاملLung Transplantation for Pulmonary Sarcoidosis
Sarcoidosis, a multisystem disorder, results in the production of multiple non-caseating granulomas capable of affecting all organs of the body. It usually occurs in patients between the ages of 10 and 40 years of age in 90% of cases. The prevalence has been reported to be 10-20 per 100,000 in the general population however the annual incidence is 107 per 100,000 (Rybicki, Major et al. 1997). T...
متن کاملRecurrent sarcoidosis after lung transplantation.
A 43-year-old man had undergone bilateral lung transplantation 2 years previously for sarcoidosis stage 4 fibrocystic disease. The patient feels well, without significant symptoms, sputa, cough or fever. A control spirometry however showed a highly obstructive, mildly restrictive pulmonary function, with a very low diffusion capacity. Laboratory results revealed a CRP of 6.4 mg/l (nl <= 5 mg/l)...
متن کاملLung transplantation for pulmonary sarcoidosis.
Patients with end-stage sarcoidosis have now undergone lung transplantation successfully with good short-term and intermediate-term results. Lung transplantation for sarcoidosis requires several considerations unique to this disease. Selection of pulmonary sarcoidosis patients for transplantation requires that medical therapy has been exhausted. This may involve the use of corticosteriods and a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: ERJ Open Research
سال: 2023
ISSN: ['2312-0541']
DOI: https://doi.org/10.1183/23120541.00738-2022